Item 9 Labs Corp., the parent company of marijuana retail franchise business Unity Rd. and Arizona cultivator Item 9 Labs, has retained Sharp Capital Advisors to help sell its business.
Phoenix-based Item 9 entered receivership in July.
Item 9 includes two operating businesses, according to the Tuesday announcement by Sharp Capital Advisors:
The company also has an incomplete 20,000-square-foot facility and “two associated licenses” in Nevada.
The company’s proposed $12.8 million acquisition of Canadian marijuana retail franchiser Sessions Cannabis was “terminated by the sellers” in May after Item 9 failed to show it had the funds to close the deal, a regulatory filing shows.
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.